Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) FCF Margin (2018 - 2025)

Neurogene's FCF Margin history spans 6 years, with the latest figure at 26975.0% for Q1 2025.

  • For Q1 2025, FCF Margin fell 70105833.0% year-over-year to 26975.0%; the TTM value through Dec 2025 reached 96595.0%, up 10434023.0%, while the annual FY2024 figure was 7720.11%, N/A changed from the prior year.
  • FCF Margin reached 26975.0% in Q1 2025 per NGNE's latest filing, up from 1700.54% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 728033.33% in Q1 2024 to a low of 1700.54% in Q2 2024.
  • Average FCF Margin over 3 years is 301285.28%, with a median of 239404.17% recorded in 2023.
  • Peak YoY movement for FCF Margin: skyrocketed 27620000bps in 2024, then crashed -70105833bps in 2025.
  • A 3-year view of FCF Margin shows it stood at 451833.33% in 2023, then tumbled by -100bps to 1700.54% in 2024, then surged by 1686bps to 26975.0% in 2025.
  • Per Business Quant, the three most recent readings for NGNE's FCF Margin are 26975.0% (Q1 2025), 1700.54% (Q2 2024), and 728033.33% (Q1 2024).